Search research articles
Contact Us
Filters
Showing results (381-390 of 413) with videos related to
Page
of 42
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2017
Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ
Chyuan-Chuan Wu, Thomas J Baiga, Michael Downes, et al.
Plos One
|
February 2, 2011
Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity
Annett Hessel, Michael Schwendinger, Georg W Holzer, et al.
Vaccine
|
August 1, 2012
A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory
Alexandra Loew-Baselli, Borislava G Pavlova, Sandor Fritsch, et al.
Plos One
|
February 27, 2015
Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs
Walter Wodal, Michael G Schwendinger, Helga Savidis-Dacho, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 20, 2006
Eugenol and isoeugenol, characteristic aromatic constituents of spices, are biosynthesized via reduction of a coniferyl alcohol ester
Takao Koeduka, Eyal Fridman, David R Gang, et al.
Plos One
|
September 3, 2010
A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations
Annett Hessel, Michael Schwendinger, Daniela Fritz, et al.
Vaccine
|
August 14, 2012
Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming
Maikel V W van der Velden, Gerald Aichinger, Eva Maria Pöllabauer, et al.
Vaccine
|
April 6, 2012
Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine
Hartmut J Ehrlich, Markus Müller, Herwig Kollaritsch, et al.
Vaccine
|
May 15, 2012
A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate
Walter Wodal, Falko G Falkner, Astrid Kerschbaum, et al.
Vaccine
|
July 7, 2007
Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses
Otfried Kistner, M Keith Howard, Martin Spruth, et al.
Page
of 42
Search research articles
Search
Showing results (381-390 of 413) with videos related to
Sort By:
Page
of 42
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2017
Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ
Chyuan-Chuan Wu, Thomas J Baiga, Michael Downes, et al.
Plos One
|
February 2, 2011
Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity
Annett Hessel, Michael Schwendinger, Georg W Holzer, et al.
Vaccine
|
August 1, 2012
A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory
Alexandra Loew-Baselli, Borislava G Pavlova, Sandor Fritsch, et al.
Plos One
|
February 27, 2015
Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs
Walter Wodal, Michael G Schwendinger, Helga Savidis-Dacho, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 20, 2006
Eugenol and isoeugenol, characteristic aromatic constituents of spices, are biosynthesized via reduction of a coniferyl alcohol ester
Takao Koeduka, Eyal Fridman, David R Gang, et al.
Plos One
|
September 3, 2010
A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations
Annett Hessel, Michael Schwendinger, Daniela Fritz, et al.
Vaccine
|
August 14, 2012
Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming
Maikel V W van der Velden, Gerald Aichinger, Eva Maria Pöllabauer, et al.
Vaccine
|
April 6, 2012
Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine
Hartmut J Ehrlich, Markus Müller, Herwig Kollaritsch, et al.
Vaccine
|
May 15, 2012
A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate
Walter Wodal, Falko G Falkner, Astrid Kerschbaum, et al.
Vaccine
|
July 7, 2007
Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses
Otfried Kistner, M Keith Howard, Martin Spruth, et al.
Page
of 42